Novus Therapeutics, Inc. (NVUS:NASDAQ) Investor Relations Material

Overview

Novus Therapeutics is a biotech firm that is currently in the clinical stage of development. The company is focused on developing potential treatments for various diseases such as autoimmune, neurodegenerative, and organ or cellular transplantation, by leveraging their expertise in targeting the CD40L pathway. The company is located in Irvine, California, USA.

Annual Reports

Frequently Asked Questions

What is Novus Therapeutics, Inc.'s ticker?

Novus Therapeutics, Inc.'s ticker is NVUS

What exchange is Novus Therapeutics, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Novus Therapeutics, Inc.'s headquarters?

They are based in Irvine, California

How many employees does Novus Therapeutics, Inc. have?

There are 1-10 employees working at Novus Therapeutics, Inc.

What is Novus Therapeutics, Inc.'s website?

It is http://novustherapeutics.com/

What type of sector is Novus Therapeutics, Inc.?

Novus Therapeutics, Inc. is in the Healthcare sector

What type of industry is Novus Therapeutics, Inc.?

Novus Therapeutics, Inc. is in the Biotechnology industry

Who are Novus Therapeutics, Inc.'s peers and competitors?

The following five companies are Novus Therapeutics, Inc.'s industry peers:

- 4D Pharma PLC

- Moleculin Biotech, Inc.

- Caladrus Biosciences

- BioNTech SE

- C4X Discovery